Cargando…

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry

INTRODUCTION: The aim of this study was to evaluate the clinical outcomes and safety of daptomycin therapy in patients with serious Gram-positive infections. METHODS: Patients were enrolled in the European Cubicin(®) Outcomes Registry and Experience (EU-CORE(SM)), a non-interventional, multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Ruiz, Armando, Gargalianos-Kakolyris, Panayiotis, Timerman, Artur, Sarma, Jayanta, José González Ramallo, Víctor, Bouylout, Kamel, Trostmann, Uwe, Pathan, Rashidkhan, Hamed, Kamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486780/ https://www.ncbi.nlm.nih.gov/pubmed/26108157 http://dx.doi.org/10.1007/s12325-015-0220-6

Ejemplares similares

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database
por: Seaton, R. Andrew, et al.
Publicado: (2013)

Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE)
por: Cogo, Alberto, et al.
Publicado: (2015)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE
por: Seaton, R. Andrew, et al.
Publicado: (2016)

Daptomycin for the Treatment of Infective Endocarditis: Results from European Cubicin(®) Outcomes Registry and Experience (EU-CORE)
por: Guleri, Achyut, et al.
Publicado: (2015)

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
por: Timerman, Artur, et al.
Publicado: (2013)

Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry
por: Keil, Felix, et al.
Publicado: (2015)

Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
por: Malizos, K., et al.
Publicado: (2015)

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2016)

Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience
por: Seaton, R. Andrew, et al.
Publicado: (2015)

Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021)

Real-World Treatment of Enterococcal Infections with Daptomycin: Insights from a Large European Registry (EU-CORE)
por: Lübbert, Christoph, et al.
Publicado: (2015)

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
por: Beiras-Fernandez, Andres, et al.
Publicado: (2010)

Daptomycin for the treatment of major gram-positive infections after cardiac surgery
por: Kornberger, A., et al.
Publicado: (2016)

New neutron-deficient isotopes of Eu, Sm and Pm
por: Westgaard, L, et al.
Publicado: (1973)

Cryostat tested at SM18 for projet EuHIT
por: Brice, Maximilien
Publicado: (2015)

Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update
por: Balice, Giuseppe, et al.
Publicado: (2022)

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-
por: Popov, Aron F, et al.
Publicado: (2011)

Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics
por: Hines, Kelly M., et al.
Publicado: (2017)

Isolated splenic cystic echinococcosis and albendazole hepatotoxicity
por: Moussas, Nikolaos, et al.
Publicado: (2022)

Clinical experience with daptomycin in Europe: the first 2.5 years
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2011)

SmS/EuS/SmS Tri-Layer Thin Films: The Role of Diffusion in the Pressure Triggered Semiconductor-Metal Transition
por: Sousanis, Andreas, et al.
Publicado: (2019)

The Effect of Different Colistin Dosing Regimens on Nephrotoxicity: A Cohort Study
por: Samarkos, Michael, et al.
Publicado: (2022)

Daptomycin therapy for Gram-positive bacterial infections: a retrospective study of 30 cardiac surgery patients
por: Douka, E, et al.
Publicado: (2008)

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients
por: Ort, Katharina R, et al.
Publicado: (2013)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)

Decay chain $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm
por: Cabrera, J A, et al.
Publicado: (1991)

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
por: Lai, Chung-Chih, et al.
Publicado: (2013)

Dermabacter hominis: a usually daptomycin-resistant gram-positive organism infrequently isolated from human clinical samples
por: Fernández-Natal, I, et al.
Publicado: (2013)

Study of $^{149}_{64}$Gd --> $^{149}_{63}$Eu --> $^{149}_{62}$Sm decay chain
por: Cabrera, J A, et al.
Publicado: (1992)

Broadband NIR photostimulated luminescence nanoprobes based on CaS:Eu(2+),Sm(3+) nanocrystals
por: Gao, Yu, et al.
Publicado: (2019)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
por: Cafiso, Viviana, et al.
Publicado: (2020)

Acute Angioedema Triggered by Daptomycin
por: Gisler, Valentin, et al.
Publicado: (2016)

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
por: Li, Shuguang, et al.
Publicado: (2017)

1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)

Daptomycin Resistant Staphylococcus aureus Clinical Strain With Novel Non-synonymous Mutations in the mprF and vraS Genes: A New Insight Into Daptomycin Resistance
por: Sabat, Artur J., et al.
Publicado: (2018)

Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based study
por: Barberán, José, et al.
Publicado: (2019)

S.M. Eisenstein : lo que solicita ser escrito /
por: González Requena, Jesús, 1955-
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_d4uvb9v3jfv8prlknok1u5ft9f